Form D · Pharmaceuticals
Aveta Biomics, Inc.
Bedford, MA · CIK 0001734691
Offering snapshot reported Mar 19, 2025 · SEC filing
- Reported sold
- $4.46M Offering amount: $8M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2025 | Initial | $4,455,040 | No comparison | 36 | SEC filing |
| Feb 23, 2022 | Initial | $600,019 | No comparison | 13 | SEC filing |
| Mar 19, 2018 | Initial | $1,100,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541386
Source: Form D, filed Mar 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guha Bala | Director |
| Peter Dolan | Director |
| S. P. Kothari | Director |
| Sp Kothari | Director |
| Parag Mehta | Director, Executive |
| Sharmila Mudgal | Director, Executive |
| David Page | Director |
| Bharat Tewarie | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
110 Great Road, Suite 302
Bedford, MA, 01730
Phone: 339-927-5994
Bedford, MA, 01730
Phone: 339-927-5994